Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2021 Filed Nov 19, 2021 21:45 UTC |
Silvestro Stephen LCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 13,241 | $7.51 | $99,439.91 |
DisclosureSEC source: 0001213900-21-060876 · ownership.xml · nonDerivative · entry 1 Silvestro Stephen L · CIK 0001773461 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:45 UTC |
FEBBO WILLIAM JDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 16,666 | $82.18 | $1,369,611.88 |
DisclosureSEC source: 0001213900-21-060341 · ownership.xml · nonDerivative · entry 1 FEBBO WILLIAM J · CIK 0001413987 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,043 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:45 UTC |
Spangler Patrick DDirector
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 6,252 | $84.38 | $527,543.76 |
DisclosureSEC source: 0001213900-21-059450 · ownership.xml · nonDerivative · entry 1 Spangler Patrick D · CIK 0001296525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,083 F1 · security: These shares sold pursuant to a plan of disposition adopted on September 7, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:45 UTC |
Odence-Ford MarionGeneral Counsel and CCO
|
GrantRestricted Stock Units · Derivative | 5,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-058166 · ownership.xml · derivative · entry 2 Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,335 Underlying: Common Stock · 5,335 shares Expires 2024-11-08 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:45 UTC |
Odence-Ford MarionGeneral Counsel and CCO
|
GrantStock Option · Derivative | 10,958 | $0.00 Strike: $93.37 | $0.00 |
DisclosureSEC source: 0001213900-21-058166 · ownership.xml · derivative · entry 1 Odence-Ford Marion · CIK 0001845002 · General Counsel and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,958 Underlying: Common Stock · 10,958 shares Expires 2026-11-08 F1 · derivative.exercise_date: The Stock Option will vest 1/3 at the end of each anniversary from issuance. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:45 UTC |
Paramore Miriam JPRES. & CHIEF STRATEGY OFFICER
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-056471 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRES. & CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,318 Underlying: Common Stock · 15,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:45 UTC |
Paramore Miriam JPRES. & CHIEF STRATEGY OFFICER
|
SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $95.45 | $1,431,750.00 |
DisclosureSEC source: 0001213900-21-056471 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRES. & CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:45 UTC |
Paramore Miriam JPRES. & CHIEF STRATEGY OFFICER
|
Exercise / conversionCommon Stock | 15,000 | $7.51 | $112,650.00 |
DisclosureSEC source: 0001213900-21-056471 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRES. & CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 20:45 UTC |
Silvestro Stephen LCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 13,241 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-053526 · ownership.xml · derivative · entry 3 Silvestro Stephen L · CIK 0001773461 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,993 Underlying: Common Stock · 13,241 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 20:45 UTC |
Silvestro Stephen LCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock pursuant to 10B5-1 plan | 13,241 | $85.38 | $1,130,516.58 |
DisclosureSEC source: 0001213900-21-053526 · ownership.xml · nonDerivative · entry 2 Silvestro Stephen L · CIK 0001773461 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 20:45 UTC |
Silvestro Stephen LCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 13,241 | $7.51 | $99,439.91 |
DisclosureSEC source: 0001213900-21-053526 · ownership.xml · nonDerivative · entry 1 Silvestro Stephen L · CIK 0001773461 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:45 UTC |
FEBBO WILLIAM JDirector · CHIEF EXECUTIVE OFFICER
|
GrantPerformance Stock Units · Derivative | 182,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-053524 · ownership.xml · derivative · entry 2 FEBBO WILLIAM J · CIK 0001413987 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,398 Underlying: Common Stock · 182,398 shares Expires 2026-10-15 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The first 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $98.87 or higher for 30 consecutive trading days during the five-year performance period. Another 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $131.82 or higher for 30 consecutive trading days during the five-year performance period. A final 34% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $164.78 or higher for 30 consecutive trading days during the five-year performance period. If earned, the performance stock units will, subject to certain exceptions, vest ratably on the first anniversary of such performance achievement. Any performance stock unit that has not been earned and vested as of the fifth anniversary of the grant date will be forfeited. Vesting of the performance stock units shall accelerate upon a qualifying termination. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The first 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $98.87 or higher for 30 consecutive trading days during the five-year performance period. Another 33% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $131.82 or higher for 30 consecutive trading days during the five-year performance period. A final 34% of the performance stock units are earned upon OptimizeRx common stock achieving an average closing price per share of $164.78 or higher for 30 consecutive trading days during the five-year performance period. If earned, the performance stock units will, subject to certain exceptions, vest ratably on the first anniversary of such performance achievement. Any performance stock unit that has not been earned and vested as of the fifth anniversary of the grant date will be forfeited. Vesting of the performance stock units shall accelerate upon a qualifying termination. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:45 UTC |
FEBBO WILLIAM JDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 16,666 | $84.20 | $1,403,277.20 |
DisclosureSEC source: 0001213900-21-053524 · ownership.xml · nonDerivative · entry 1 FEBBO WILLIAM J · CIK 0001413987 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,709 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 20:45 UTC |
Stelmakh EdwardCOO and CFO
|
GrantStock Option · Derivative | 25,191 | $0.00 Strike: $81.09 | $0.00 |
DisclosureSEC source: 0001213900-21-052644 · ownership.xml · derivative · entry 2 Stelmakh Edward · CIK 0001887046 · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,191 Underlying: Common Stock · 25,191 shares Expires 2026-10-11 F4 · derivative.exercise_date: The Stock Option will vest 1/3 at the end of each anniversary from issuance. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 20:45 UTC |
Stelmakh EdwardCOO and CFO
|
GrantRestricted Stock Units · Derivative | 24,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-052644 · ownership.xml · derivative · entry 1 Stelmakh Edward · CIK 0001887046 · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,664 Underlying: Common Stock · 24,664 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted will vest 1/3 at the end of each anniversary from issuance, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 10,000 | $7.51 Strike: $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · derivative · entry 4 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,699 Underlying: Common Stock · 10,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 10,000 | $82.35 | $823,500.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · nonDerivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $84.22 | $336,880.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,796 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:45 UTC |
Paramore Miriam JPRESIDENT AND CSO
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-051450 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,318 Underlying: Common Stock · 15,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:45 UTC |
Paramore Miriam JPRESIDENT AND CSO
|
SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $84.67 | $1,270,050.00 |
DisclosureSEC source: 0001213900-21-051450 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:45 UTC |
Paramore Miriam JPRESIDENT AND CSO
|
Exercise / conversionCommon Stock | 15,000 | $7.51 | $112,650.00 |
DisclosureSEC source: 0001213900-21-051450 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:45 UTC |
Lang James PaulDirector
|
GrantRestricted Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-051142 · ownership.xml · derivative · entry 1 Lang James Paul · CIK 0001703090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334 Underlying: Common Stock · 334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:45 UTC |
WASSON GREGORY DDirector
|
GrantRestricted Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-051141 · ownership.xml · derivative · entry 1 WASSON GREGORY D · CIK 0001188827 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334 Underlying: Common Stock · 334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:45 UTC |
HALAS GUS DDirector
|
GrantRestricted Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-051140 · ownership.xml · derivative · entry 1 HALAS GUS D · CIK 0001230322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334 Underlying: Common Stock · 334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:45 UTC |
Spangler Patrick DDirector
|
GrantRestricted Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-051138 · ownership.xml · derivative · entry 1 Spangler Patrick D · CIK 0001296525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334 Underlying: Common Stock · 334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:45 UTC |
Vos Ellen O'ConnorDirector
|
GrantRestricted Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-051139 · ownership.xml · derivative · entry 1 Vos Ellen O'Connor · CIK 0001534357 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334 Underlying: Common Stock · 334 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 2,000 | $74.66 | $149,320.00 |
DisclosureSEC source: 0001213900-21-050600 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $70.59 | $282,360.00 |
DisclosureSEC source: 0001213900-21-049366 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 20:45 UTC | Exercise / conversionStock Option · Derivative | 13,242 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-049127 · ownership.xml · derivative · entry 3 Silvestro Stephen L · CIK 0001773461 · CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,234 Underlying: Common Stock · 13,242 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| September 17, 2021 Filed Sep 21, 2021 20:45 UTC | SaleCommon Stock pursuant to 10B5-1 plan | 13,242 | $69.79 | $924,159.18 |
DisclosureSEC source: 0001213900-21-049127 · ownership.xml · nonDerivative · entry 2 Silvestro Stephen L · CIK 0001773461 · CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
|
| September 17, 2021 Filed Sep 21, 2021 20:45 UTC | Exercise / conversionCommon Stock | 13,242 | $7.51 | $99,447.42 |
DisclosureSEC source: 0001213900-21-049127 · ownership.xml · nonDerivative · entry 1 Silvestro Stephen L · CIK 0001773461 · CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| September 15, 2021 Filed Sep 17, 2021 20:45 UTC |
FEBBO WILLIAM JDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 16,666 | $65.74 | $1,095,622.84 |
DisclosureSEC source: 0001213900-21-048613 · ownership.xml · nonDerivative · entry 1 FEBBO WILLIAM J · CIK 0001413987 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,375 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 3,768 | $65.57 | $247,067.76 |
DisclosureSEC source: 0001213900-21-048250 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:45 UTC |
FEBBO WILLIAM JDirector · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 8,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-048251 · ownership.xml · nonDerivative · entry 1 FEBBO WILLIAM J · CIK 0001413987 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,041 F1 · shares: Shares represent a charitable gift/donation to the National Philanthropic Trust/William and Vanessa Febbo. The Reporting Person is not a Trustee and has no pecuniary interest or investment discretion. F2 · price: Price is not applicable to acquisitions or dispositions resulting from bona fide gifts. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 16:46 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 10,000 | $7.51 Strike: $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · derivative · entry 4 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,699 Underlying: Common Stock · 10,000 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 16:46 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 10,000 | $67.25 | $672,500.00 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · nonDerivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,564 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 16:46 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,000 | $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 16:46 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 2,232 | $70.53 | $157,422.96 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,564 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:45 UTC |
Paramore Miriam JPRESIDENT AND CSO
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-046665 · ownership.xml · derivative · entry 3 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,318 Underlying: Common Stock · 15,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:45 UTC |
Paramore Miriam JPRESIDENT AND CSO
|
SaleCommon Stock Pursuant to 10B5-1 Plan | 15,000 | $68.39 | $1,025,850.00 |
DisclosureSEC source: 0001213900-21-046665 · ownership.xml · nonDerivative · entry 2 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,607 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:45 UTC |
Paramore Miriam JPRESIDENT AND CSO
|
Exercise / conversionCommon Stock | 15,000 | $7.51 | $112,650.00 |
DisclosureSEC source: 0001213900-21-046665 · ownership.xml · nonDerivative · entry 1 Paramore Miriam J · CIK 0001713156 · PRESIDENT AND CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 16:46 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $66.62 | $266,480.00 |
DisclosureSEC source: 0001213900-21-046409 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 24, 2021 Filed Aug 24, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $61.50 | $246,000.00 |
DisclosureSEC source: 0001213900-21-044609 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,796 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 16:45 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 5,000 | $58.45 | $292,250.00 |
DisclosureSEC source: 0001213900-21-044609 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 17, 2021 Filed Aug 17, 2021 16:46 UTC |
BAKER DOUGLAS PCHIEF FINANCIAL OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $58.46 | $233,840.00 |
DisclosureSEC source: 0001213900-21-043479 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,796 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:45 UTC |
Silvestro Stephen LCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 13,242 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001213900-21-043903 · ownership.xml · derivative · entry 3 Silvestro Stephen L · CIK 0001773461 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,476 Underlying: Common Stock · 13,242 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:45 UTC |
Silvestro Stephen LCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock pursuant to 10B5-1 plan | 13,242 | $58.41 | $773,465.22 |
DisclosureSEC source: 0001213900-21-043903 · ownership.xml · nonDerivative · entry 2 Silvestro Stephen L · CIK 0001773461 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:45 UTC |
Silvestro Stephen LCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 13,242 | $7.51 | $99,447.42 |
DisclosureSEC source: 0001213900-21-043903 · ownership.xml · nonDerivative · entry 1 Silvestro Stephen L · CIK 0001773461 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:46 UTC |
FEBBO WILLIAM JDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock (pursuant to 10B5-1 plan) | 16,666 | $60.46 | $1,007,626.36 |
DisclosureSEC source: 0001213900-21-043480 · ownership.xml · nonDerivative · entry 1 FEBBO WILLIAM J · CIK 0001413987 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,641 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 28, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.